Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials. - Graeser M; Schrading S; Gluz O; Strobel K; Würstlein R; Kümmel S; Schumacher C; Grischke EM; Forstbauer H; Braun M; Christgen M; Adams J; et al. (International journal of cancer, 2021)